Composition & Format Peptide: Ipamorelin (synthetic pentapeptide growth hormone secretagogue) Strengths available: 5 mg and 10 mg per vial Configuration: clamshell trays with 10 vials per kit , suitable for bulk and OEM programs Appearance: white lyophilized powder designed for reconstitution in laboratory settings Origin: China-based peptide factory with established export track record Key Features for Wholesale Buyers Factory-direct supply from a China-based GMP-compliant peptide manufacturer High-purity material (99%) with batch documentation available for qualified buyers Consistent lot-to-lot quality to support long-term research projects Bulk-ready kits with protective clamshell trays for easier handling and inventory control OEM and private-label options available for established distributors on request Packaging & Ordering Standard kit: 10 vials of Ipamorelin lyophilized powder per clamshell tray Packaging designed for international transport with protective cushioning and insulation as needed Suitable for consolidating peptide orders in one shipment for laboratories and distributors Wholesale and OEM enquiries can be placed via email or messaging apps listed on our contact page Orders are typically processed with dispatch updates provided within three business days after payment confirmation Storage & Handling Store Ipamorelin vials sealed at 28 C , protected from light and moisture Avoid repeated freezethaw cycles and handle under appropriate laboratory conditions Reconstituted solutions should be used according to your internal lab protocols and stability assessments Related Products CJC-1295 (no DAC) GHRH peptide kit CJC-1295 (no DAC) 5 mg + Ipamorelin 5 mg blend peptide kit Blue Top HGH growth hormone peptide kit IGF-1 LR3 growth factor peptide kit NAD+ 500 mg recovery-focused peptide kit Compliance & Notes Produced in GMP-compliant facilities in China for export to qualified research organizations For laboratory research use only

PlexusDx partners with licensed 503A compounders to deliver personalized semaglutide therapy at $189/mo month-to-month, or from $149/mo on the 6-month plan, with no insurance requirement and full HSA/FSA eligibility
In the completed STEP trials, semaglutide 2.4 mg as an adjunct to lifestyle intervention led to mean body weight losses of ~1517% over 68 weeks in patients without T2D (STEP 1, 3 and 4), with a smaller mean weight loss of 9.6% seen in patients with T2D over the same period (STEP 2)
Additionally, Farxigas diuretic effect can cause volume depletion and low blood pressure, particularly in elderly patients or during summer months when dehydration risk is elevated
Further 3D classifications focusing on the alignment on the whole complex and the receptor produced one high-quality subset accounting for 255,256 particles
Semaglutide is not indicated for the treatment of type 1 diabetes